摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3,4-Dihydro-2H-quinolin-1-yl)[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone | 1000686-33-8

中文名称
——
中文别名
——
英文名称
(3,4-Dihydro-2H-quinolin-1-yl)[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone
英文别名
(3-(1H-pyrazol-4-yl)pyrrolidin-1-yl)(3,4-dihydroquinolin-1(2H)-yl)methanone;3,4-dihydro-2H-quinolin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone
(3,4-Dihydro-2H-quinolin-1-yl)[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone化学式
CAS
1000686-33-8
化学式
C17H20N4O
mdl
——
分子量
296.372
InChiKey
CWTOLCPMXYKCCN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    52.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    tert-butyl 3-(1H-pyrazol-4-yl)-2,5-dihydropyrrole-1-carboxylate 在 盐酸 、 palladium on carbon 、 氢气 作用下, 以 1,4-二氧六环乙醇二氯甲烷 为溶剂, 生成 (3,4-Dihydro-2H-quinolin-1-yl)[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone
    参考文献:
    名称:
    Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1
    摘要:
    A High Throughput Screening campaign allowed the identification of a novel class of ureas as 11 beta-HSD1 inhibitors. Rational chemical optimization provided potent and selective inhibitors of both human and murine 11 beta-HSD1 with an appropriate ADME profile and ex vivo activity in target tissues. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.02.111
点击查看最新优质反应信息

文献信息

  • DERIVATIVES OF UREAS OF PIPERIDINE OR PYRROLIDINE, THEIR PREPARATION AND THEIR THERAPEUTICAL USE
    申请人:BRAUN Alain
    公开号:US20090176775A1
    公开(公告)日:2009-07-09
    The present invention is related to a compound of formula (I): wherein i, j, n, o, p, q, r, R 1a , R 1b , R 1c , R 1d , R 2a , R 2b , R 2c , R 2d , R 3a , R 3b and R 4 are as defined herein, or an addition salt with an acid thereof, or a hydrate or solvate thereof, its preparation, pharmaceutical composition, and uses for treating a disease in which the enzyme 11β-HSD1 is involved.
    本发明涉及一种具有以下式(I)的化合物: 其中i、j、n、o、p、q、r、R1a、R1b、R1c、R1d、R2a、R2b、R2c、R2d、R3a、R3b和R4如本文所定义,或其与酸的加合盐,或其水合物或溶剂合物,其制备、药物组合物以及用于治疗11β-HSD1酶参与的疾病的用途。
  • Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1
    作者:Olivier Venier、Cécile Pascal、Alain Braun、Claudie Namane、Patrick Mougenot、Olivier Crespin、François Pacquet、Cécile Mougenot、Catherine Monseau、Bénédicte Onofri、Rommel Dadji-Faïhun、Céline Leger、Majdi Ben-Hassine、Thao Van-Pham、Jean-Luc Ragot、Christophe Philippo、Stefan Güssregen、Christian Engel、Géraldine Farjot、Lionel Noah、Karima Maniani、Eric Nicolaï
    DOI:10.1016/j.bmcl.2011.02.111
    日期:2011.4
    A High Throughput Screening campaign allowed the identification of a novel class of ureas as 11 beta-HSD1 inhibitors. Rational chemical optimization provided potent and selective inhibitors of both human and murine 11 beta-HSD1 with an appropriate ADME profile and ex vivo activity in target tissues. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多